In cancer, biomarkers are features of the tumor, such as a genetic mutation or the presence of a certain protein. These biomarkers affect how the cancer behaves. Doctors use the results of biomarker testing to make treatment recommendations. Several organizations, including the American Cancer Society and the LUNGevity Foundation, through the No One Missed campaign, are working to pass laws to require insurance coverage for biomarker testing for people with cancer. Joanna Fawzy Doran, CEO of Triage Cancer, discusses some of the issues people face getting biomarker testing covered by insurance and how the new laws are helping. Listen to the episode to hear Joanna talk about: which biomarker tests are less likely to be covered by insurance the insurance plans the laws do and don’t apply to the options people have when a health insurance carrier denies coverage for a biomarker test deemed necessary by a doctor

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related